Stockreport

BELLUS Health Announces Positive Interim Analysis from the Phase 2b SOOTHE Trial of BLU-5937 in Refractory Chronic Cough

BELLUS Health Inc. - Common Shares  (BLU) 
Last bellus health inc. - common shares earnings: 11/14 07:00 am Check Earnings Report
PDF Interim analysis met the threshold for a high probability of clinical efficacy Data from interim analysis support accelerated planning for the Phase 3 programSOOTHE Phas [Read more]